MY Stock MarketDetailed Quotes

0252 ORGABIO

Watchlist

0.380
+0.015+4.11%

15min DelayMarket Closed Dec 31 16:33 CST

94.19MMarket Cap18.10P/E (TTM)

ORGABIO Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Sep 30, 2024

(FY)Jun 30, 2024

(Q4)Jun 30, 2024

(Q3)Mar 31, 2024

(Q2)Dec 31, 2023

(Q1)Sep 30, 2023

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(Q3)Mar 31, 2023

(Q2)Dec 31, 2022

Total revenue

92.93%23.44M

26.01%74.14M

58.08%20.9M

82.08%22.43M

-0.86%18.66M

-16.06%12.15M

-8.58%58.84M

-17.49%13.22M

-8.64%12.32M

18.82M

Cost of revenue

90.41%18.91M

23.05%60.26M

54.20%17.34M

68.65%18.06M

-8.51%14.94M

-7.15%9.93M

-3.01%48.97M

-7.84%11.24M

7.93%10.71M

16.33M

Gross profit

104.19%4.53M

40.71%13.87M

80.03%3.57M

171.37%4.37M

49.40%3.72M

-41.25%2.22M

-28.85%9.86M

-48.22%1.98M

-54.80%1.61M

2.49M

Operating expense

7.73%1.95M

-15.88%7.95M

26.65%2.11M

-7.32%2.03M

18.26%2M

-53.59%1.81M

62.81%9.45M

-3.98%1.67M

36.35%2.19M

1.69M

Selling and administrative expenses

7.73%1.95M

-15.88%7.95M

26.65%2.11M

-7.32%2.03M

18.26%2M

-53.59%1.81M

62.81%9.45M

-3.98%1.67M

36.35%2.19M

--1.69M

-Selling and marketing expense

475.00%23K

157.49%20.51K

7,268.57%2.51K

-33.33%2K

--12K

0.00%4K

26.83%7.97K

-112.50%-35

-50.00%3K

--0

-General and administrative expense

6.69%1.93M

-16.02%7.93M

26.50%2.11M

-7.28%2.03M

17.55%1.98M

-53.64%1.81M

62.85%9.44M

-3.97%1.67M

36.67%2.18M

--1.69M

Operating profit

532.60%2.58M

1,336.69%5.93M

364.11%1.46M

505.89%2.34M

114.98%1.72M

426.40%408K

-94.88%412.57K

-85.00%313.57K

-129.47%-577K

801K

Net non-operating interest income (expenses)

4.52%-148K

6.28%-556.93K

5.14%-134.93K

9.15%-129K

13.75%-138K

-3.33%-155K

-3.81%-594.23K

5.45%-142.23K

-0.71%-142K

-160K

Non-operating interest expense

-4.52%148K

-6.28%556.93K

-5.14%134.93K

-9.15%129K

-13.75%138K

3.33%155K

3.81%594.23K

-5.45%142.23K

0.71%142K

--160K

Net investment income

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

-3,600.00%-37K

-58.13%-18.07K

-9.75%5.93K

-127.78%-5K

19.05%-17K

-133.33%-1K

-565.57%-11.43K

176.94%6.58K

18K

-21K

Less:Write off

3,600.00%37K

58.13%18.07K

9.75%-5.93K

127.78%5K

-19.05%17K

133.33%1K

565.57%11.43K

-176.94%-6.58K

---18K

--21K

Other non-operating income (expenses)

-467.50%-681K

-14.41%294.56K

-80.67%94.56K

222.45%158K

143.47%163K

-173.62%-120K

-32.82%344.16K

18.36%489.16K

226.67%49K

-375K

Income before tax

1,199.24%1.72M

3,637.93%5.65M

113.00%1.42M

462.88%2.37M

606.12%1.73M

221.10%132K

-98.11%151.07K

-71.55%667.07K

-135.59%-652K

245K

Income tax

650.00%645K

48.83%1.54M

1,131.93%447.96K

161.70%246K

224.36%759K

-87.13%86K

-53.80%1.03M

-94.56%36.36K

-79.25%94K

234K

Net income

2,226.09%1.07M

565.71%4.11M

54.25%972.89K

384.18%2.12M

8,727.27%971K

105.92%46K

-115.31%-882.29K

-62.37%630.71K

-154.10%-746K

11K

Net income continuous operations

2,226.09%1.07M

565.71%4.11M

54.25%972.89K

384.18%2.12M

8,727.27%971K

105.92%46K

-115.31%-882.29K

-62.37%630.71K

-154.10%-746K

--11K

Noncontrolling interests

Net income attributable to the company

2,226.09%1.07M

565.71%4.11M

54.25%972.89K

384.18%2.12M

8,727.27%971K

105.92%46K

-115.31%-882.29K

-62.37%630.71K

-154.10%-746K

11K

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

2,226.09%1.07M

565.71%4.11M

54.25%972.89K

384.18%2.12M

8,727.27%971K

105.92%46K

-115.31%-882.29K

-62.37%630.71K

-154.10%-746K

11K

Gross dividend payment

Basic earnings per share

2,050.00%0.0043

561.11%0.0166

53.85%0.004

383.33%0.0085

3,800.00%0.0039

106.25%0.0002

-115.49%-0.0036

-61.55%0.0026

-153.93%-0.003

0.0001

Diluted earnings per share

2,050.00%0.0043

561.11%0.0166

53.85%0.004

383.33%0.0085

3,800.00%0.0039

106.25%0.0002

-115.49%-0.0036

-61.55%0.0026

-153.93%-0.003

0.0001

Dividend per share

Accounting Standards

NonUS-GAAP

	(Q1)Sep 30, 2024	(FY)Jun 30, 2024	(Q4)Jun 30, 2024	(Q3)Mar 31, 2024	(Q2)Dec 31, 2023	(Q1)Sep 30, 2023	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(Q3)Mar 31, 2023	(Q2)Dec 31, 2022
Total revenue	92.93%23.44M	26.01%74.14M	58.08%20.9M	82.08%22.43M	-0.86%18.66M	-16.06%12.15M	-8.58%58.84M	-17.49%13.22M	-8.64%12.32M	18.82M
Cost of revenue	90.41%18.91M	23.05%60.26M	54.20%17.34M	68.65%18.06M	-8.51%14.94M	-7.15%9.93M	-3.01%48.97M	-7.84%11.24M	7.93%10.71M	16.33M
Gross profit	104.19%4.53M	40.71%13.87M	80.03%3.57M	171.37%4.37M	49.40%3.72M	-41.25%2.22M	-28.85%9.86M	-48.22%1.98M	-54.80%1.61M	2.49M
Operating expense	7.73%1.95M	-15.88%7.95M	26.65%2.11M	-7.32%2.03M	18.26%2M	-53.59%1.81M	62.81%9.45M	-3.98%1.67M	36.35%2.19M	1.69M
Selling and administrative expenses	7.73%1.95M	-15.88%7.95M	26.65%2.11M	-7.32%2.03M	18.26%2M	-53.59%1.81M	62.81%9.45M	-3.98%1.67M	36.35%2.19M	--1.69M
-Selling and marketing expense	475.00%23K	157.49%20.51K	7,268.57%2.51K	-33.33%2K	--12K	0.00%4K	26.83%7.97K	-112.50%-35	-50.00%3K	--0
-General and administrative expense	6.69%1.93M	-16.02%7.93M	26.50%2.11M	-7.28%2.03M	17.55%1.98M	-53.64%1.81M	62.85%9.44M	-3.97%1.67M	36.67%2.18M	--1.69M
Operating profit	532.60%2.58M	1,336.69%5.93M	364.11%1.46M	505.89%2.34M	114.98%1.72M	426.40%408K	-94.88%412.57K	-85.00%313.57K	-129.47%-577K	801K
Net non-operating interest income (expenses)	4.52%-148K	6.28%-556.93K	5.14%-134.93K	9.15%-129K	13.75%-138K	-3.33%-155K	-3.81%-594.23K	5.45%-142.23K	-0.71%-142K	-160K
Non-operating interest expense	-4.52%148K	-6.28%556.93K	-5.14%134.93K	-9.15%129K	-13.75%138K	3.33%155K	3.81%594.23K	-5.45%142.23K	0.71%142K	--160K
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)	-3,600.00%-37K	-58.13%-18.07K	-9.75%5.93K	-127.78%-5K	19.05%-17K	-133.33%-1K	-565.57%-11.43K	176.94%6.58K	18K	-21K
Less:Write off	3,600.00%37K	58.13%18.07K	9.75%-5.93K	127.78%5K	-19.05%17K	133.33%1K	565.57%11.43K	-176.94%-6.58K	---18K	--21K
Other non-operating income (expenses)	-467.50%-681K	-14.41%294.56K	-80.67%94.56K	222.45%158K	143.47%163K	-173.62%-120K	-32.82%344.16K	18.36%489.16K	226.67%49K	-375K
Income before tax	1,199.24%1.72M	3,637.93%5.65M	113.00%1.42M	462.88%2.37M	606.12%1.73M	221.10%132K	-98.11%151.07K	-71.55%667.07K	-135.59%-652K	245K
Income tax	650.00%645K	48.83%1.54M	1,131.93%447.96K	161.70%246K	224.36%759K	-87.13%86K	-53.80%1.03M	-94.56%36.36K	-79.25%94K	234K
Net income	2,226.09%1.07M	565.71%4.11M	54.25%972.89K	384.18%2.12M	8,727.27%971K	105.92%46K	-115.31%-882.29K	-62.37%630.71K	-154.10%-746K	11K
Net income continuous operations	2,226.09%1.07M	565.71%4.11M	54.25%972.89K	384.18%2.12M	8,727.27%971K	105.92%46K	-115.31%-882.29K	-62.37%630.71K	-154.10%-746K	--11K
Noncontrolling interests
Net income attributable to the company	2,226.09%1.07M	565.71%4.11M	54.25%972.89K	384.18%2.12M	8,727.27%971K	105.92%46K	-115.31%-882.29K	-62.37%630.71K	-154.10%-746K	11K
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	2,226.09%1.07M	565.71%4.11M	54.25%972.89K	384.18%2.12M	8,727.27%971K	105.92%46K	-115.31%-882.29K	-62.37%630.71K	-154.10%-746K	11K
Gross dividend payment
Basic earnings per share	2,050.00%0.0043	561.11%0.0166	53.85%0.004	383.33%0.0085	3,800.00%0.0039	106.25%0.0002	-115.49%-0.0036	-61.55%0.0026	-153.93%-0.003	0.0001
Diluted earnings per share	2,050.00%0.0043	561.11%0.0166	53.85%0.004	383.33%0.0085	3,800.00%0.0039	106.25%0.0002	-115.49%-0.0036	-61.55%0.0026	-153.93%-0.003	0.0001
Dividend per share
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Symbol Price % Chg